News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Drug Development
Sound Pharmaceuticals, Inc. Release: New Drug For Hearing Loss Enters Clinical Testing
June 12, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
SEATTLE, June 12 /PRNewswire/ -- Sound Pharmaceuticals initiates clinical testing of SPI-1005 for the prevention and treatment of noise induced hearing loss.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase I
Sound Pharmaceuticals
MORE ON THIS TOPIC
Approvals
CSL Wins First Approval for Preventive Hereditary Angioedema Drug
June 18, 2025
·
2 min read
·
Tristan Manalac
Parkinson’s disease
Ventyx’s Parkinson’s Pill Shows ‘Promising’ Results in Mid-Stage Study, Paving Path to Other Neuro Diseases
June 17, 2025
·
2 min read
·
Tristan Manalac
Cancer
Roche, AbbVie’s Venclexta Stumbles Again, This Time in Myelodysplastic Syndromes
June 17, 2025
·
1 min read
·
Tristan Manalac
Weight loss
Lilly Notches ‘Top-Tier’ Weight Loss Results for Phase I Amylin/Tirzepatide Combo
June 16, 2025
·
2 min read
·
Annalee Armstrong
